Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
about
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesConsiderations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant eraAssessing the risk of recurrent venous thromboembolism--a practical approachRecurrent venous thromboembolism: what is the risk and how to prevent itManaging pulmonary embolism using prognostic models: future concepts for primary carePredicting the risk of venous thromboembolism recurrenceEffectiveness of d-dimer as a screening test for venous thromboembolism: an updateThe epidemiology of venous thromboembolismGuidance for the treatment of deep vein thrombosis and pulmonary embolismRisk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsDuration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysisD-Dimer elevation and adverse outcomesRisk factors for venous thrombosis associated with peripherally inserted central venous catheters.Delineating the Hemostaseome as an aid to individualize the analysis of the hereditary basis of thrombotic and bleeding disorders.Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approachPulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolismImmediate Discharge and Home Treatment With Rivaroxaban of Low-risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: A One-year Preplanned AnalysisWhich patients with unprovoked VTE should receive extended anticoagulation? the minority.Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.Using the laboratory to predict recurrent venous thrombosis.Difficulties in diagnosing pulmonary embolism in the obese patient: a literature review.Postintervention duration of anticoagulation in venous surgery.Management of venous thromboembolism--controversies and the future.Optimal treatment duration of venous thrombosis.How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.Predicting the risk of recurrent venous thromboembolism (VTE).ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.Cancer-Associated Venous Thromboembolism.Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism.In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments.The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal.Review of D-dimer testing: Good, Bad, and Ugly.D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.Acute Unilateral Renal Infarction in the Setting of an Inherited Thrombophilia and Atrial Septal DefectEpidemiology of venous thromboembolism.Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study.
P2860
Q24633053-4276C61B-74CC-4DDF-851B-5C080FAA3505Q26765299-63503D61-74EF-462A-B75C-93922F0F8106Q26796430-20B00CD4-2B9E-458D-8AB7-83288CE77872Q26826847-28B25DDE-20CB-4332-85A8-0A558C44C38CQ26830769-8150BE40-3B79-4B47-AC34-48CD5B236971Q26865059-8A65EA59-6504-4C87-9F83-32077E48A0E8Q27001045-7C26D572-B5CA-434B-8EA8-2D5BCF1E3D51Q28067893-5F1DC4C6-5E0A-4018-92B1-A702C7DAA155Q28078989-72ADC774-AA8B-41CD-A873-40F5D45CD362Q30889099-BB5DDD18-F985-4131-BA55-EC256A3E6232Q33910755-BCA63CC9-45BC-4438-9FC8-DDD10D29B81FQ34254243-0F4D8C90-6900-4283-A586-A560BE4F7201Q34525565-EE24DE23-B9E5-49A5-9406-4A1213EAE947Q34603112-40C256B7-F78D-4A74-A92B-9CEA7312BD6EQ34990303-55993E76-D03D-4831-AE70-502B93097225Q35017431-C6854391-9CB9-45D4-8406-C82F5F66F75CQ35105533-B6EA0370-6950-483B-A8A8-79F38AB117BCQ36377944-BA41B242-EAA0-47BB-B3C2-D5F93B0053B7Q36718482-391BE3E5-13DA-4922-AAB2-C654FD9B30E1Q37033151-D561E739-5DCA-4B20-B047-C6FF1653A56AQ37279270-79FD97FD-70C7-4347-A068-B1DDF80D4AA9Q37843743-B09FB651-F21B-4B90-BA3C-E4B4DA530037Q37844472-483D9628-462A-4409-B173-0DE153DCC095Q37892665-D4935389-B5F6-4DE2-A057-A83A5B93FE0EQ37949309-3C186600-484F-42F7-B038-424456E44E8BQ38088606-7387AC38-0EA1-4F6F-A269-F9FDAD45BA6FQ38093286-BD427549-214A-48FA-A476-9558AACF32EFQ38117732-CA41CB78-2BDD-46C7-81B0-CDAC7F82647EQ38263114-43630C65-3AED-4D5E-A722-6E9F2974A12BQ38365637-E81D4CFB-04AC-4E4A-B16A-297B081DBF89Q38656360-4260DC90-6D49-4CEC-8FE0-44DAB7784EC2Q38748038-87AE9503-41F7-4992-A633-5FF62B9450ADQ38777416-DBA4DADD-F4C8-4649-A71A-DCD7AFC83512Q38834390-8FD9C258-78EB-4764-B9F2-B3F053506ADBQ38987037-491AC8CF-59E0-48D4-93DD-EF560BBD75F5Q39266318-0152488C-32C7-44BD-B355-E1DAFE1CCF88Q40347859-B8221EAB-BD9D-42AC-8E06-A5757C7347AEQ41448500-926B9CD2-4826-433F-BE20-38E9D65F13A6Q41667853-CC836F1B-14AE-41B9-8559-C905C9B935CDQ41702785-421516D4-7516-4E23-98B9-3A3BEBB79A52
P2860
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@ast
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@en
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@nl
type
label
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@ast
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@en
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@nl
prefLabel
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@ast
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@en
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@nl
P2093
P921
P1476
Patient-level meta-analysis: e ...... ovoked venous thromboembolism.
@en
P2093
Alberto Tosetto
Daniela Poli
Gualtiero Palareti
James Douketis
Maura Marcucci
R Campbell Tait
Sabine Eichinger
Trevor Baglin
P304
P356
10.7326/0003-4819-153-8-201010190-00009
P407
P577
2010-10-01T00:00:00Z